Literature DB >> 23125875

Attenuated psychosis and the schizophrenia prodrome: current status of risk identification and psychosis prevention.

Neeraj Tandon1, Jai Shah, Matcheri S Keshavan, Rajiv Tandon.   

Abstract

Recent efforts in the prevention of schizophrenia have focused on defining psychosis-risk syndromes and evaluating treatments that can prevent transition to psychosis in these ultra-high risk groups. In this review, different kinds of prevention approaches are enumerated and necessary conditions for a disease-prevention strategy are summarized. The broad overlap as well as the significant difference between a schizophrenia prodrome and a 'psychosis-risk syndrome' is discussed and the present status of approaches to identify individuals at increased risk for developing psychosis and schizophrenia are critically examined along with evaluations on therapeutic interventions to reduce these risks. Finally, to conclude, recommendations for current best clinical practice and key questions for the future are suggested.

Entities:  

Year:  2012        PMID: 23125875      PMCID: PMC3483069          DOI: 10.2217/npy.12.36

Source DB:  PubMed          Journal:  Neuropsychiatry (London)        ISSN: 1758-2008


  70 in total

1.  The search for modifiable risk factors for schizophrenia.

Authors:  John J McGrath; Debbie A Lawlor
Journal:  Am J Psychiatry       Date:  2011-12       Impact factor: 18.112

2.  Recovery from an at-risk state: clinical and functional outcomes of putatively prodromal youth who do not develop psychosis.

Authors:  Danielle A Schlosser; Sarah Jacobson; Qiaolin Chen; Catherine A Sugar; Tara A Niendam; Gang Li; Carrie E Bearden; Tyrone D Cannon
Journal:  Schizophr Bull       Date:  2011-08-08       Impact factor: 9.306

3.  Disordered corticolimbic interactions during affective processing in children and adolescents at risk for schizophrenia revealed by functional magnetic resonance imaging and dynamic causal modeling.

Authors:  Vaibhav A Diwadkar; Sunali Wadehra; Patrick Pruitt; Matcheri S Keshavan; Usha Rajan; Caroline Zajac-Benitez; Simon B Eickhoff
Journal:  Arch Gen Psychiatry       Date:  2012-03

4.  The psychosis threshold in Ultra High Risk (prodromal) research: is it valid?

Authors:  Alison R Yung; Barnaby Nelson; Andrew Thompson; Stephen J Wood
Journal:  Schizophr Res       Date:  2010-04-08       Impact factor: 4.939

5.  Diagnosing schizophrenia in the initial prodromal phase.

Authors:  J Klosterkötter; M Hellmich; E M Steinmeyer; F Schultze-Lutter
Journal:  Arch Gen Psychiatry       Date:  2001-02

Review 6.  Prevention of schizophrenia: can it be achieved?

Authors:  Cheng Lee; Thomas H McGlashan; Scott W Woods
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

Review 7.  Intervention in individuals at ultra-high risk for psychosis: a review and future directions.

Authors:  Patrick D McGorry; Barnaby Nelson; G Paul Amminger; Andreas Bechdolf; Shona M Francey; Gregor Berger; Anita Riecher-Rössler; Joachim Klosterkötter; Stephan Ruhrmann; Frauke Schultze-Lutter; Merete Nordentoft; Ian Hickie; Philip McGuire; Michael Berk; Eric Y H Chen; Matcheri S Keshavan; Alison R Yung
Journal:  J Clin Psychiatry       Date:  2009-06-30       Impact factor: 4.384

8.  Progressive brain structural changes mapped as psychosis develops in 'at risk' individuals.

Authors:  Daqiang Sun; Lisa Phillips; Dennis Velakoulis; Alison Yung; Patrick D McGorry; Stephen J Wood; Theo G M van Erp; Paul M Thompson; Arthur W Toga; Tyrone D Cannon; Christos Pantelis
Journal:  Schizophr Res       Date:  2009-01-12       Impact factor: 4.939

Review 9.  Schizophrenia, "just the facts" what we know in 2008. 2. Epidemiology and etiology.

Authors:  Rajiv Tandon; Matcheri S Keshavan; Henry A Nasrallah
Journal:  Schizophr Res       Date:  2008-06-02       Impact factor: 4.939

10.  Anticipating DSM-V: should psychosis risk become a diagnostic class?

Authors:  William T Carpenter
Journal:  Schizophr Bull       Date:  2009-07-24       Impact factor: 9.306

View more
  14 in total

Review 1.  DSM-5 reviewed from different angles: goal attainment, rationality, use of evidence, consequences—part 2: bipolar disorders, schizophrenia spectrum disorders, anxiety disorders, obsessive-compulsive disorders, trauma- and stressor-related disorders, personality disorders, substance-related and addictive disorders, neurocognitive disorders.

Authors:  Hans-Jürgen Möller; Borwin Bandelow; Michael Bauer; Harald Hampel; Sabine C Herpertz; Michael Soyka; Utako B Barnikol; Simone Lista; Emanuel Severus; Wolfgang Maier
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-08-26       Impact factor: 5.270

Review 2.  Attenuated psychosis syndrome in DSM-5.

Authors:  Ming T Tsuang; Jim Van Os; Rajiv Tandon; Deanna M Barch; Juan Bustillo; Wolfgang Gaebel; Raquel E Gur; Stephan Heckers; Dolores Malaspina; Michael J Owen; Susan Schultz; William Carpenter
Journal:  Schizophr Res       Date:  2013-06-14       Impact factor: 4.939

Review 3.  Psychosis prediction and clinical utility in familial high-risk studies: selective review, synthesis, and implications for early detection and intervention.

Authors:  Jai L Shah; Neeraj Tandon; Matcheri S Keshavan
Journal:  Early Interv Psychiatry       Date:  2013-05-22       Impact factor: 2.732

4.  Stratifying empiric risk of schizophrenia among first degree relatives using multiple predictors in two independent Indian samples.

Authors:  Triptish Bhatia; Elizabeth A Gettig; Irving I Gottesman; Jonathan Berliner; N N Mishra; Vishwajit L Nimgaonkar; Smita N Deshpande
Journal:  Asian J Psychiatr       Date:  2016-08-21

5.  Clinical psychopathology in youth at familial high risk for psychosis.

Authors:  Jai L Shah; Neeraj Tandon; Debra M Montrose; Diana Mermon; Shaun M Eack; Jean Miewald; Matcheri S Keshavan
Journal:  Early Interv Psychiatry       Date:  2017-09-07       Impact factor: 2.732

6.  Correspondence between psychometric and clinical high risk for psychosis in an undergraduate population.

Authors:  David C Cicero; Elizabeth A Martin; Theresa M Becker; Anna R Docherty; John G Kerns
Journal:  Psychol Assess       Date:  2014-04-07

Review 7.  New drug developments in psychosis: Challenges, opportunities and strategies.

Authors:  Matcheri S Keshavan; Ashley N Lawler; Henry A Nasrallah; Rajiv Tandon
Journal:  Prog Neurobiol       Date:  2016-08-09       Impact factor: 11.685

Review 8.  The Enigma of Prodromes in Hereditary Angioedema (HAE).

Authors:  Iris Leibovich-Nassi; Avner Reshef
Journal:  Clin Rev Allergy Immunol       Date:  2021-02-03       Impact factor: 8.667

9.  Timing, Distribution, and Relationship Between Nonpsychotic and Subthreshold Psychotic Symptoms Prior to Emergence of a First Episode of Psychosis.

Authors:  Lani Cupo; Sarah V McIlwaine; Jean-Gabriel Daneault; Ashok K Malla; Srividya N Iyer; Ridha Joober; Jai L Shah
Journal:  Schizophr Bull       Date:  2021-04-29       Impact factor: 9.306

10.  Schizophrenia and Other Psychotic Disorders in Diagnostic and Statistical Manual of Mental Disorders (DSM)-5: Clinical Implications of Revisions from DSM-IV.

Authors:  Rajiv Tandon
Journal:  Indian J Psychol Med       Date:  2014-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.